3Poon R T,Fan S T,Lo C M,et al.Improving survival results after resection of hepatocellular carcinoma:a prospective study of 377 patients over 10 years[J].Ann Surg,2001,234(1):63-70.
4Fong Y,Sun R L,Jarnagin W,et al.An analysis of 412 cases of hepatocellular carcinoma at a Western center[J].Ann Surg,1999,229(6):790-799.
7Wayne J D,Lauwers G Y,Ikai I,et al.Preoperative predictors of survival after resection of small hepatocellular carcinomas[J].Ann Surg,2002,235(5):722-731.
8Arii S,Yamaoka Y,Futagawa S,et al.Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas:a retrospective and nationwide survey in Japan.The Liver Cancer Study Group of Japan[J].Hepatology,2000,32(6):1224-1229.
4Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coil Sttrg, 2000,191:381-388.
5Yamanaka N, Okamoto E, Toyosaka A, et al. Criteria of curability in the resection therapy for hepatocellular carcinoma. Nippon Gan Chiryo Gakkai Shi, 1989,24 : 1592-1599.
6Harada T, Kodama S, Matsuo K, et al. Surgical management of large hepatocellular carcinoma: criteria for curative hepatectomy. Int Surg,1993. 78:284-287.
7Kosuge T, Makuuchi M, Takayama T, et al. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepato Gastroenterology, 1993, 40:328-332.
8Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellularcar cinoma after surgery. Br J Surg, 1996,83 : 1219-1222.
9Okada S, Shimada K, Yamamoto J, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology,1994, 106:1618-1624.
10Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology, 2000,214:761-768.
7Jiang Long,Zhen-Wei Lang,Hua-Guang Wang,Tai-Ling Wang,Bao-En Wang and Si-Qi Liu Liver Research Center,Beijing Friendship Hospital, Capital Medical University,Beijing 100050,China,Department of Hepatology,Department of Pathology, Beijing Youan Hospital,Capital Medical University,Beijing 100069,China,Department of Pharmaceutical Affairs,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China,Department of Pathology,China-Japan Friendship Hospital,Beijing 100029,China,Beijing Genomics Institute,Chinese Academy of Science,Beijing Airport Industrial Zone B-6,Shunyi,Beijing 101300,China.Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected smal hepatocel ular carcinomas[J].Hepatobiliary & Pancreatic Diseases International,2010,9(3):296-305. 被引量：21
